Caring for Women With Parkinson Disease
Episode 93, Jul 14, 2023, 10:00 AM
Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.
In this episode, we spoke with Jill Farmer, DO, MPH, an assistant professor of neurology and director of the Parkinson’s Disease & Movement Disorder Program at Global Neurosciences Institute, who spoke with us about the current landscape of care for women with Parkinson disease (PD), how the approach to their care can differ from men, the major gaps around education and treatment for these women, and much more.
Looking for more Movement Disorder discussion? Check out the NeurologyLive® movement disorder clinical focus page.
Episode Breakdown:
In this episode, we spoke with Jill Farmer, DO, MPH, an assistant professor of neurology and director of the Parkinson’s Disease & Movement Disorder Program at Global Neurosciences Institute, who spoke with us about the current landscape of care for women with Parkinson disease (PD), how the approach to their care can differ from men, the major gaps around education and treatment for these women, and much more.
Looking for more Movement Disorder discussion? Check out the NeurologyLive® movement disorder clinical focus page.
Episode Breakdown:
- 1:15 – The presentation of Parkinson disease for women
- 3:00 – Nonmotor symptoms that can create challenges for diagnosis
- 4:45 – OFF episodes and dyskinesia in women vs men
- 7:00 – Being attentive to patient needs in treatment
- 10:20 – The daily impact of Parkinson disease
- 13:05 – Neurology News Minute
- 16:30 – Encouraging women with Parkinson to participate in trials
- 18:30 – Barriers to care specific to women
- 20:00 – Communication with women patients
- 22:20 – Areas of need for research
- 23:35 – Conversations in areas of limited knowledge
- 25:20 – Closing thoughts
This episode is brought to you by Medical World News, a streaming channel from MJH Life Sciences®. Check out new content and shows every day, only at medicalworldnews.com.
The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:
- FDA Issues Complete Response Letter to Amneal for Parkinson Agent IPX203
- FDA Grants Traditional Approval to Lecanemab as Therapy for Early-Stage Alzheimer Disease
- Medicare Expands Coverage for Fully Approved Alzheimer Agent Lecanemab
- FDA Approves Image Guided Programming Software for Vercise Deep Brain Stimulation Systems
Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.